Article
[Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis].
Problemy tuberkuleza - 1 Jan 2002
Vasil'eva I A, Chernousova L N, Zasedatelev A S, Sobolev A Iu, Mikhaĭlovich V M
Abstract excerpt
The patients with multiresistant tuberculosis were divided into 2 groups: the sensitivity of Mycobacteria tuberculosis to antituberculous drugs was evaluated in Group 1 by the methods of absolute concentrations and in Group 2 by biological microchips determining mutations in the rpo3 gene responsible for rifampicin resistance. The results of the drug sensitivity test were obtained after 3 months of treatment in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
